To achieve our vision of a world without ALS, we support nearly every stage of research, from identifying ALS-linked genes and biomarkers to discovering and developing new treatments to optimizing current treatment approaches and quality of life. We also encourage young scientists to pursue careers in ALS and build research and clinical trial infrastructure to cultivate a robust pipeline of innovative ideas that can lead to better ALS treatments and ultimately a cure.
Lawrence and Isabel Barnett Drug Development Program
This grant program supports preclinical drug discovery and development of new or repurposed treatments for ALS.
These awards, established in partnership with the American Academy of Neurology and American Brain Foundation, give young investigators the experience they need to establish their own ALS research laboratories and continue moving their innovative ideas toward the clinic.
To help make ALS a livable disease until we can cure it, we annually review and refine our research portfolio with input from our Research Committee. Click below to explore current and past requests for applications.